Bowel Obstruction
Population-based appraisal of small bowel obstruction is presented
Published in Medical Letter on the CDC and FDA, October 8th, 2006
"Small bowel obstruction (SBO) is a common reason for surgical consultation, but little is known about the natural history of SBO. We performed a population-based analysis to evaluate SBO frequency, type of operation, and long-term outcomes," scientists in the United States report.
"Using the California Inpatient File, we identified all patients admitted in 1997 with a diagnosis of SBO," said Nova M. Foster and colleagues at the University of California-Los Angeles. "Patients were excluded if they...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Antibacterial Agents
Intrapartum antibiotics prevent Escherichia coli infection only for term infants - Cancer Therapy
Antitumor responses are enhanced by B-cell depletion via decrease in IL-10 production - Cardiovascular Disease
Inhibition of rapamycin target modulates adhesion molecule expression - HIV/AIDS Epidemiology
HIV/AIDS epidemiology of adolescents and young adults in U.S. is reported - Rotavirus Vaccine
Restricting rotavirus vaccination schedule did not decrease risk of intussusception - Alcohol Use
Adolescent alcohol abuse and dependence are affected by parental factors - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
